Results 11 to 20 of about 268,416 (278)
Frontiers in Immunology, 2022 Coronavirus disease 2019 (COVID-19) vaccines effectively elicit humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in healthy populations. This immunity decreases several months after vaccination.
Michal Podrazil +8 more
doaj +1 more source
Kinetics of severe acute respiratory syndrome coronavirus 2 infection antibody responses
Frontiers in Immunology, 2022 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly throughout the world, causing severe morbidity and mortality. Since the first reports of Coronavirus disease 2019 (COVID-19) in late 2019, research on the characteristics of ...
Yajie Lin +7 more
doaj +1 more source
Immune correlates of protection following Rift Valley fever virus vaccination
npj Vaccines, 2022 Rift Valley fever virus (RVFV) is a hemorrhagic fever virus with the potential for significant economic and public health impact. Vaccination with an attenuated strain, DelNSsRVFV, provides protection from an otherwise lethal RVFV challenge, but ...
Joshua D. Doyle +3 more
doaj +1 more source
Pathogens and Immunity, 2021 Background: The role of humoral immunity has been well established in reducing infection risk and facilitating viral clearance in patients with COVID-19. However, the relationship between specific antibody responses and severity of COVID-19 is less well
Jessica Jones +4 more
doaj +1 more source
Influenza and memory T cells : how to awake the force [PDF]
, 2016 Annual influenza vaccination is an effective way to prevent human influenza. Current vaccines are mainly focused on eliciting a strain-matched humoral immune response, requiring yearly updates, and do not provide protection for all vaccinated individuals.
Glezen +12 more
core +3 more sources
Reviewing the effects of food provisioning on wildlife immunity [PDF]
, 2018 While urban expansion increasingly encroaches on natural habitats, many wildlife species capitalize on anthropogenic food resources, which have the potential to both positively and negatively influence their responses to infection.
Babayan, Simon A. +2 more
core +1 more source
Circumventing antivector immunity: potential use of nonhuman adenoviral vectors [PDF]
, 2014 Adenoviruses are efficient gene delivery vectors based on their ability to transduce a wide variety of cell types and drive high-level transient transgene expression. While there have been advances in modifying human adenoviral (HAdV) vectors to increase
Beard C.W. +30 more
core +3 more sources
Scientific Reports, 2022 The lipid nanoparticle (LNP)-formulated mRNA vaccines BNT162b2 and mRNA-1273 are a widely adopted multi vaccination public health strategy to manage the COVID-19 pandemic. Clinical trial data has described the immunogenicity of the vaccine, albeit within
Chapin S. Korosec +8 more
doaj +1 more source
Comparison of the humoral and cellular immunity in COVID-19 convalescents
Инфекция и иммунитет, 2022 The SARS-CoV-2 virus caused the COVID-19 pandemic is related to the SARS-CoV-1 and MERS coronaviruses, which were resulted in 2003 and 2012 epidemics. Antibodies in patients with COVID-19 emerge 714 days after the onset of symptoms and gradually increase.
Anna P. Toptygina +3 more
doaj +1 more source
The role of the immune response in the etiopathogenesis of endometriosis [PDF]
Romanian Medical Journal, 2021 Endometriosis is a benign, chronic, estrogen-dependent condition, present in 10% of women of reproductive age. The condition is associated with chronic pelvic pain and infertility that influence their quality of life, as well as married life and has ...
Catalina Diana Stanica +3 more
doaj +1 more source